Evidence map›Paper›PMID 33375121›Full record

ArticleInternational journal of molecular sciences2020

CD85k Contributes to Regulatory T Cell Function in Chronic Viral Infections.

Anna Estrada Brull, Felix Rost, Josua Oderbolz, Florian R Kirchner, Salomé Leibundgut-Landmann, Annette Oxenius, Nicole Joller

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. From chaos to control: Nobel insights in regulatory T cells and immune tolerance.Pflugers Archiv : European journal of physiology · 2025
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anna Estrada BrullInstitute of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland.
Felix RostInstitute of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland.ORCID 0000-0002-1606-2893
Josua OderbolzETH Zurich, Institute of Microbiology, 8093 Zurich, Switzerland.
Florian R KirchnerInstitute of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland.
Salomé Leibundgut-LandmannInstitute of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland.ORCID 0000-0002-5724-4837
Annette OxeniusETH Zurich, Institute of Microbiology, 8093 Zurich, Switzerland.
Nicole JollerInstitute of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland.ORCID 0000-0003-1996-1672
University of Zurich · CHETH Zurich · CH

Funding

H2020 European Research Council 677200Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 310030_166206Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung PP00P3_181037
6 · The paper itself

Abstract

Regulatory T cells (Tregs) prevent excessive immune responses and limit immune pathology upon infections. To fulfill this role in different immune environments elicited by different types of pathogens, Tregs undergo functional specialization into distinct subsets. During acute type 1 immune responses, type 1 Tregs are induced and recruited to the site of ongoing Th1 responses to efficiently control Th1 responses. However, whether a similar specialization process also takes place following chronic infections is still unknown. In this study, we investigated Treg specialization in persistent viral infections using lymphocytic choriomeningitis virus (LCMV) and murine cytomegalovirus (MCMV) infection as models for chronic and latent infections, respectively. We identify CD85k as a Th1-specific co-inhibitory receptor with sustained expression in persistent viral infections and show that recombinant CD85k inhibits LCMV-specific effector T cells. Furthermore, expression of the CD85k ligand ALCAM is induced on LCMV-specific and exhausted T cells during chronic LCMV infection. Finally, we demonstrate that type 1 Tregs arising during chronic LCMV infection suppress Th1 effector cells in an ALCAM-dependent manner. These results extend the current knowledge of Treg specialization from acute to persistent viral infections and reveal an important functional role of CD85k in Treg-mediated suppression of type 1 immunity.

Indexed as

AnimalsAntigens, CDCell Adhesion Molecules, NeuronalCell LineCells, CulturedHerpesviridae InfectionsLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMembrane GlycoproteinsMice, Inbred C57BLMuromegalovirusReceptors, ImmunologicTh1 CellsT-Lymphocytes, RegulatoryAntigens, CDCell Adhesion Molecules, NeuronalMembrane GlycoproteinsReceptors, ImmunologicALCAMCD85kchronic viral infectionregulatory T cells

Identifiers

PMID33375121
PMCPMC7792974
OpenAlexW3115989633

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.